European Patent Office

T 1780/12 (Cancer treatment/BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM) of 30.01.2014

European Case Law Identifier
ECLI:EP:BA:2014:T178012.20140130
Date of decision
30 January 2014
Case number
T 1780/12
Petition for review of
-
Application number
04007843.8
Language of proceedings
English
Distribution
Distributed to board chairmen and members (B)
OJ versions
No OJ links found
Other decisions for this case
-
Abstracts for this decision
-
Application title
Uses of antibodies to aminophospholipids for cancer treatment
Applicant name
BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
Opponent name
-
Board
3.3.04
Headnote
-
Relevant legal provisions
European Patent Convention Art 111(1)
Keywords
Double patenting (no) - not the same subject-matter
Remittal to the department of first instance - (yes)
Catchword
See points 16 to 25 of the Reasons

Order

For these reasons it is decided that:

1. The decision under appeal is set aside.

2. The case is remitted to the department of first instance for further prosecution on the basis of the main request filed with the statement of grounds of appeal.